Table 2.
Treatment | 17β-Estradiol | Progesterone |
---|---|---|
Sham at Estrus | 6.4 ± 0.6* | 5,151.5 ± 888.6† |
Ovariectomized | ||
Placebo | 3.9 ± 0.2 | 554.4 ± 79.5 |
17β-Estradiol | 88.7 ± 14.6 ‡ | 3,019.1 ± 866.2† |
Progesterone | 7.7 ± 2.0 | 3,511.6 ± 361.5‡ |
17β-Estradiol + progesterone | 56.0 ± 8.3‡ | 5,607.3 ± 379.8‡ |
Control at Estrus | 11.7 ± 3.5 | 4,155.0 ± 262.0 |
Tamoxifen | 16.8 ± 5.8 | 1,697.5 ± 111.7† |
Values are expressed as means ± SE in pg/ml (n=10). Assessment of the effect of castration and hormonal replacement on plasma sex steroid levels. Plasma sex steroid hormone concentration in C57BL/6J female mice at estrus or following ovariectomy and hormonal replacement with 17β-estradiol and/or progesterone.
P < 0.05, † P < 0.01,‡P < 0.001.